EP2557985A1 - Medizinisches gerätesystem - Google Patents
Medizinisches gerätesystemInfo
- Publication number
- EP2557985A1 EP2557985A1 EP11719169A EP11719169A EP2557985A1 EP 2557985 A1 EP2557985 A1 EP 2557985A1 EP 11719169 A EP11719169 A EP 11719169A EP 11719169 A EP11719169 A EP 11719169A EP 2557985 A1 EP2557985 A1 EP 2557985A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- medication
- spectrometer
- signal processing
- signal
- interface
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
- A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
Definitions
- the invention is directed to a medical device system by which a medication of a patient is tuned in accordance with continuously acquired physiological measurement signals.
- the invention has for its object to provide solutions by which a medication of a patient with high accuracy can be achieved.
- a medical device system comprising:
- a spectrometer device for collecting measurement signals from vital tissue of a patient, in particular for the continuous determination of the composition of body fluids as well as vessel-bound substances which may be present only temporarily in the corresponding tissue region,
- a signal processing device for processing the measurement signals supplied by the spectrometer device and for generating a medication signal
- a medication device for administering a medicament in accordance with the medication signal
- the signal processing device has a first interface for connecting the spectrometer device, a second interface device for connecting the medicating device, and a third interface
- the third interface means the evaluation of the measurement signals supplied by the spectrometer device and the Determination procedure for the medication signal are configurable.
- the signal processing device can be controlled and configured in an advantageous manner after connection of the system to the patient.
- About the third interface device can preferably also on the part of
- Spectrometer device generated raw data can be read.
- the spectrometer device and the signal processing device are preferably configured in such a way that the acquisition of the spectra takes place at such a high sampling rate that cell-dynamic processes, in particular vasomotion effects, can be detected. This makes it possible to tune the medication in consideration of conditions that can be recognized by closely correlated cell dynamics phenomena.
- signal processing programs can preferably be fed into each of the third interface device via the third interface device
- Signal processing device are read, which are initially kept in an operating computer system, for example, as so-called. Tools.
- Signal processing device preferably takes place via a user interface which makes it possible to determine the function of the signal processing device by means of drag and drop routines, as well as by graphically supported range and parameter options.
- the control-relevant substances and phenomena can be selected via the drag-and-drop function. The meaning of these selected substances and phenomena can then be adjusted by means of the selection of the species.
- Medication needs special rule concepts kept the then the doctor may still narrow limits can be varied.
- the components of the system are each provided with a specific coding, so that, for example, provided for the dosage of a drug procedure only the activation of a corresponding
- Medication device allows.
- the signal processor may be configured to output the medication signal as a scalar in a range of 0-99.
- the spectrometer device may be designed such that it comprises a measuring head that can be attached to a selected tissue region of the patient, and that this measuring head is coupled to an analysis module via an optical waveguide device, wherein the signal processing device is integrated into that analysis module.
- FIG. 1 shows a sketch to illustrate the structure of a medical device system according to the invention.
- FIG. 1 shows a medical device system according to the invention. This includes a spectrometer device for collecting measurement signals from vital tissue of a patient, in particular for the continuous determination of the
- Composition of body fluids as well as vessel-bound substances present only temporarily in the corresponding tissue area.
- Skeprometer comprises a measuring head 1 which is connected here by way of example via a bracelet 2 to a patient 3. This measuring head is connected via a fiber optic cable L with a measuring device 4.
- the measuring device 4 includes the spectrometer device and a programmable signal processing device 5 for
- the signal processing device 5 is further designed in such a way that it can generate a medication signal by means of which a medication device 6 is controlled.
- the medication device 6 serves to administer a medicament in accordance with the abovementioned
- the signal processing device has a first interface for connecting the spectrometer device, a second interface device for connecting the medicating device, and a third interface device, wherein the evaluation of the measurement signals supplied by the spectrometer device and the determination procedure for the medicament signal can be configured via the third interface device.
- Signal processing device a configuration computer 7 are separated from the system.
- the medication then takes place directly in accordance with the spectrometric measurement on the patient and the stored and configured in the signal processing device program.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102010014703A DE102010014703A1 (de) | 2010-04-12 | 2010-04-12 | Medizinisches Gerätesystem |
PCT/EP2011/001792 WO2011128054A1 (de) | 2010-04-12 | 2011-04-11 | Medizinisches gerätesystem |
Publications (1)
Publication Number | Publication Date |
---|---|
EP2557985A1 true EP2557985A1 (de) | 2013-02-20 |
Family
ID=44118709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP11719169A Withdrawn EP2557985A1 (de) | 2010-04-12 | 2011-04-11 | Medizinisches gerätesystem |
Country Status (6)
Country | Link |
---|---|
US (1) | US20130131587A1 (zh) |
EP (1) | EP2557985A1 (zh) |
JP (1) | JP2013539989A (zh) |
CN (1) | CN103079458A (zh) |
DE (1) | DE102010014703A1 (zh) |
WO (1) | WO2011128054A1 (zh) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4975581A (en) * | 1989-06-21 | 1990-12-04 | University Of New Mexico | Method of and apparatus for determining the similarity of a biological analyte from a model constructed from known biological fluids |
KR20140134338A (ko) * | 2003-09-11 | 2014-11-21 | 테라노스, 인코포레이티드 | 피분석물의 모니터링 및 약물 전달을 위한 의료 기기 |
US20060229515A1 (en) * | 2004-11-17 | 2006-10-12 | The Regents Of The University Of California | Fiber optic evaluation of tissue modification |
WO2008029403A1 (en) * | 2006-09-06 | 2008-03-13 | Medingo Ltd. | Fluid delivery system with optical sensing of analyte concentration levels |
CN101605494A (zh) * | 2006-10-27 | 2009-12-16 | 阿里戴斯公司 | 使用相干喇曼技术及其校准技术用于医疗诊断和治疗目的 |
WO2009066288A1 (en) * | 2007-11-21 | 2009-05-28 | Medingo Ltd. | Analyte monitoring and fluid dispensing system |
-
2010
- 2010-04-12 DE DE102010014703A patent/DE102010014703A1/de not_active Withdrawn
-
2011
- 2011-04-11 CN CN2011800289444A patent/CN103079458A/zh active Pending
- 2011-04-11 WO PCT/EP2011/001792 patent/WO2011128054A1/de active Application Filing
- 2011-04-11 EP EP11719169A patent/EP2557985A1/de not_active Withdrawn
- 2011-04-11 US US13/639,419 patent/US20130131587A1/en not_active Abandoned
- 2011-04-11 JP JP2013504157A patent/JP2013539989A/ja not_active Withdrawn
Non-Patent Citations (1)
Title |
---|
See references of WO2011128054A1 * |
Also Published As
Publication number | Publication date |
---|---|
DE102010014703A1 (de) | 2011-10-13 |
CN103079458A (zh) | 2013-05-01 |
WO2011128054A1 (de) | 2011-10-20 |
JP2013539989A (ja) | 2013-10-31 |
US20130131587A1 (en) | 2013-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60312737T2 (de) | Verfahren und Vorrichtung zur Messung von Blutbestandteilen | |
Weiergräber et al. | Sampling rate, signal bandwidth and related pitfalls in EEG analysis | |
DD300132A5 (de) | Einrichtung und verfahren zum nachweisen und messen der konzentration von substanzen in einer probe durch optoakustische spektroskopie | |
Hayes et al. | Interpreting deactivations in neuroimaging | |
DE102006002045A1 (de) | Vorrichtung zum Analysieren der Herzfrequenzvariabilität | |
DE10211765B4 (de) | Vorrichtung zur Lokalisation des Zielpunktes von Elektroden zur Hirnstimulation, insbesondere zur Tiefenhirnstimulation | |
EP2608718A1 (de) | Medizinisches handmessgerät mit austauschbarer sonde | |
EP2305112A1 (de) | Bioimpedanzmessvorrichtung | |
EP2557985A1 (de) | Medizinisches gerätesystem | |
DE69731348T2 (de) | Vorrichtung zur graphischen Darstellung der im Körper gegenwärtigen angekoppelten Therapien- und messgeräte | |
DE212008000064U1 (de) | Vorrichtung zur Überwachung der Diabetes-Insulin-Therapie | |
DE102008007593A1 (de) | Vorrichtung zur Geometriemessung an einem Werkstück und Verfahren zur Geometriemessung an einem Werkstück | |
DE102011102854A1 (de) | Vorrichtung zur modularen Auswertung | |
WO2010054646A2 (de) | Verfahren zum erzeugen von bilddaten für eine darstellung eines instrumentes und system | |
DE102014105463A1 (de) | Verfahren zur Bestimmung des emotionalen Erregungsgrades einer Person | |
Cunningham | The application of b-mode ultrasonography for analysis of human skeletal muscle | |
WO2021185609A1 (de) | Sensor befestigung für einwegbehälter | |
WO2018188699A1 (de) | Analysevorrichtung | |
DE10241071B4 (de) | Vorrichtung zum Lokalisieren bestimmter Substanzen in einem tierischen oder menschlichen Körper | |
LU101301B1 (de) | Blutuntersuchungsgerät | |
DE102018009740A1 (de) | Fußkraft-Messvorrichtung Pedomotograph | |
WO2019002318A1 (de) | Minimalinvasive untersuchungsvorrichtung | |
DE10084059B4 (de) | Spektrometrische Sonde | |
Schneider | Analytical insights at the point-of-need with antibody-based methods | |
AT509725B1 (de) | Durchflussmesseinrichtung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20121112 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20161101 |